Reports
Reports
Sale
The global urine monitoring systems market size was valued at USD 571.55 million in 2023, driven by the emphasis on continuous urine flow monitoring for kidney failure in critically ill patients globally. The market is expected to grow at a CAGR of 9.2% during the forecast period of 2024-2032, with the values likely to rise from USD 624.14 million in 2024 to USD 1,262.00 million by 2032.
Urine monitoring system is a diagnostic method to assess and monitor urine output of an ICU patient. It is used to measure urine flow and volume in patients. If the kidneys are producing an adequate amount of urine, it indicates that they are oxygenated and well perfused, otherwise, the person might be suffering from some pathological issue.
Careful and regular urine monitoring can also lead to early detection of an acute kidney injury (AKI), oliguria (low urine output) along with better fluid management in the body. With effective technical advancements, urine monitoring systems are now both manual and automatic.
Acute kidney injury is a common illness among ICU-admitted patients, associated with high morbidity and mortality. It occurs in over 55% of the ICU patients. In such conditions, optimal fluid management holds high significance for early detection and avoiding complications. Patients with such critical complications need a urine monitoring system on high priority. Therefore, the market size for urine monitoring system has increased over the years.
In any critical care unit, almost all vitals are measured electronically to provide continuous and precise readings. Manual recording can be time-consuming and require visual evaluation along with data recording. Nowadays, healthcare practitioners widely rely on automated devices to get every minute detail so that they can minimise any chance of error. Hence, urine monitoring systems market growth can be anticipated in the forthcoming years with the rising need for automated devices.
Market Breakup by Product Type
Market Breakup by Usage
Market Breakup by End User
Market Breakup by Region
Approximately 5.7 million people are admitted to ICUs annually in the United States alone. More than 1 in every 7 United States adults, which turns out be around 35.5 million people are estimated to have a chronic kidney disease. With the rising demand for solutions, there have been several advancements to deal with the ailments. Hence, the North American region has held the largest urine monitoring systems market share.
In the coming years, the market share appears to be making a shift. Asian countries, like Taiwan and Japan, now have a high prevalence for kidney failures, followed by Mexico. Hence, the need for urine monitoring systems is predicted to increase and deviate from the existing market share.
Urine monitoring systems are also a necessity for people with diabetic nephropathy as well. Diabetic nephropathy is a condition that affects the kidneys’ natural ability to filter out toxins and wastes. Early detection and regular monitoring can lower the risk of complications. Since, the Asian region including China and Pakistan have a high rate of diabetic patients, a surge in the demand for such devices can be anticipated in the territory.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Usage |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Urine Monitoring Systems Market Overview
3.1 Global Urine Monitoring Systems Market Historical Value (2017-2023)
3.2 Global Urine Monitoring Systems Market Forecast Value (2024-2032)
4 Global Urine Monitoring Systems Market Landscape
4.1 Global Urine Monitoring Systems Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Urine Monitoring Systems Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Usage
5 Global Urine Monitoring Systems Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Urine Monitoring Systems Market Segmentation
6.1 Global Urine Monitoring Systems Market by Product Type
6.1.1 Market Overview
6.1.2 Manual
6.1.3 Automatic
6.2 Global Urine Monitoring Systems Market by Usage
6.2.1 Market Overview
6.2.2 Disposable
6.2.3 Reusable
6.3 Global Urine Monitoring Systems Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Specialty Clinics
6.3.4 Others
6.4 Global Urine Monitoring Systems Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Urine Monitoring Systems Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Urine Monitoring Systems Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Urine Monitoring Systems Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Urine Monitoring Systems Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Urine Monitoring Systems Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Future Path Medical Holding Company LLC
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Cardinal Health
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Potrero Medical
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Navamedic ASA
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 F. Hoffmann-La Roche Ltd.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 RenalSense Ltd.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Roche Holding AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Medispec Ltd
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
18 Global Urine Monitoring Systems Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 571.55 million in 2023 driven the emphasis on continuous urine output monitoring for patients in intensive care units (ICU).
The market is anticipated to grow at a CAGR of 9.2% during the forecast period of 2024-2032, likely to reach a market value of USD 1,262.00 million by 2032.
The market demand is expected to grow with the rising prevalence of renal failures, acute kidney injuries and diabetes.
The automated urine monitoring system has gained prominence over the manual system as it provides real time and precise readings. Also, the North American region has been the biggest market in the historical period. However, the Asian region is expected to observe a growth in the coming years.
There are both manual and automatic urine monitoring systems in the market.
Urine monitoring systems consist of reusable and disposable products.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
The end users in the market include hospitals, speciality clinics, and others.
Key players involved in the market are Future Path Medical Holding Company LLC, Cardinal Health, Potrero Medical, Navamedic ASA, F. Hoffmann-La Roche Ltd., RenalSense Ltd., Roche Holding AG, Medispec Ltd.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.